These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 1847022)
1. Influence of C-ANF receptor and neutral endopeptidase on pharmacokinetics of ANF in rats. Chiu PJ; Tetzloff G; Romano MT; Foster CJ; Sybertz EJ Am J Physiol; 1991 Jan; 260(1 Pt 2):R208-16. PubMed ID: 1847022 [TBL] [Abstract][Full Text] [Related]
2. The pharmacokinetics of 125I-atrial natriuretic factor in anaesthetized rats. Effects of neutral endopeptidase inhibition with candoxatrilat and of ANF-C receptor blockade. Barclay PL; Bennett JA; Greengrass PM; Griffin A; Samuels GM; Shepperson NB Biochem Pharmacol; 1992 Sep; 44(6):1013-22. PubMed ID: 1417928 [TBL] [Abstract][Full Text] [Related]
3. Basal and volume expansion-stimulated plasma atrial natriuretic peptide concentrations and hemodynamics in conscious rats: effects of SCH 39.370, an endopeptidase inhibitor, and C-ANF-(4-23), a clearance receptor ligand. Kukkonen P; Vuolteenaho O; Ruskoaho H Endocrinology; 1992 Feb; 130(2):755-65. PubMed ID: 1531129 [TBL] [Abstract][Full Text] [Related]
4. Clearance function of type C receptors of atrial natriuretic factor in rats. Almeida FA; Suzuki M; Scarborough RM; Lewicki JA; Maack T Am J Physiol; 1989 Feb; 256(2 Pt 2):R469-75. PubMed ID: 2537040 [TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of ANF and urodilatin during cANF receptor blockade and neutral endopeptidase inhibition. Abassi ZA; Tate J; Hunsberger S; Klein H; Trachewsky D; Keiser HR Am J Physiol; 1992 Nov; 263(5 Pt 1):E870-6. PubMed ID: 1443119 [TBL] [Abstract][Full Text] [Related]
6. Clearance receptor and neutral endopeptidase-mediated metabolism of atrial natriuretic factor. Okolicany J; McEnroe GA; Koh GY; Lewicki JA; Maack T Am J Physiol; 1992 Sep; 263(3 Pt 2):F546-53. PubMed ID: 1415584 [TBL] [Abstract][Full Text] [Related]
8. Neutral metalloendopeptidase inhibitors as ANF potentiators: sites and mechanisms of action. Sybertz EJ; Chiu PJ; Watkins RW; Vemulapalli S Can J Physiol Pharmacol; 1991 Oct; 69(10):1628-35. PubMed ID: 1838029 [TBL] [Abstract][Full Text] [Related]
9. The blood pressure and renal responses to SCH 34826, a neutral metalloendopeptidase inhibitor, and C-ANF (4-23) in Doca-salt hypertensive rats. Vemulapalli S; Chiu PJ; Brown A; Griscti K; Sybertz EJ Life Sci; 1991; 49(5):383-91. PubMed ID: 1649942 [TBL] [Abstract][Full Text] [Related]
10. Neutral metalloendopeptidase inhibition: a novel means of circulatory modulation. Sybertz EJ; Chiu PJ; Watkins RW; Vemulapalli S J Hypertens Suppl; 1990 Dec; 8(7):S161-7. PubMed ID: 2151333 [TBL] [Abstract][Full Text] [Related]
11. Atrial natriuretic factor potentiating and hemodynamic effects of SCH 42495, a new, neutral metalloendopeptidase inhibitor. Watkins RW; Vemulapalli S; Chiu PJ; Foster C; Smith EM; Neustadt B; Haslanger M; Sybertz EJ Am J Hypertens; 1993 May; 6(5 Pt 1):357-68. PubMed ID: 8512660 [TBL] [Abstract][Full Text] [Related]
12. Role of the endopeptidase 24.11 in the disposition and metabolism of endogenous atrial natriuretic factor in the rabbit. Marleau S; Nguyen TT; Du Souich P; Bellemare M; De Lean A; Ong H Drug Metab Dispos; 1991; 19(1):194-9. PubMed ID: 1673398 [TBL] [Abstract][Full Text] [Related]
13. Possible regulation of atrial natriuretic factor by neutral endopeptidase 24.11 and clearance receptors. Seymour AA; Norman JA; Asaad MM; Fennell SA; Abboa-Offei B; Little DK; Kratunis VJ; Delaney NG; Hunt JT; Di Donato G J Pharmacol Exp Ther; 1991 Mar; 256(3):1002-9. PubMed ID: 1826031 [TBL] [Abstract][Full Text] [Related]
14. High salt intake-induced changes in atrial natriuretic factor kinetics are mediated by clearance receptors. Widimsky J; Kuchel O; Debinski W; Du Souich P Proc Soc Exp Biol Med; 1991 Oct; 198(1):555-60. PubMed ID: 1653959 [TBL] [Abstract][Full Text] [Related]
15. Metabolic clearance of atrial natriuretic factor in ovine pregnancy. Mukaddam-Daher S; Gutkowska J; Nuwayhid BS; Quillen EW Am J Physiol; 1994 Nov; 267(5 Pt 2):R1413-20. PubMed ID: 7977873 [TBL] [Abstract][Full Text] [Related]
16. ANF disappearance and tissue distribution in rats. Widimsky J; Debinski W; Kuchel O; Buu NT Am J Physiol; 1990 Jan; 258(1 Pt 2):H134-9. PubMed ID: 2137296 [TBL] [Abstract][Full Text] [Related]
17. Hemodynamic and hormonal effects of neutral endopeptidase inhibitor SCH 39370 in sheep. Charles CJ; Espiner EA; Cameron VA; Richards AM; Yandle TG; Sybertz EJ Hypertension; 1991 May; 17(5):643-51. PubMed ID: 1850715 [TBL] [Abstract][Full Text] [Related]
18. Hemodynamic effects of atrial natriuretic factor clearance receptor occupancy in conscious sheep. Parkes DG; Coghlan JP; Lewicki JA; Scarborough RM; Scoggins BA Am J Hypertens; 1990 Nov; 3(11):829-32. PubMed ID: 2175624 [TBL] [Abstract][Full Text] [Related]
19. Inactivation of atrial natriuretic factor in mice in vivo: crucial role of enkephalinase (EC 3.4.24.11). Gros C; Souque A; Schwartz JC Eur J Pharmacol; 1990 Apr; 179(1-2):45-56. PubMed ID: 2142086 [TBL] [Abstract][Full Text] [Related]
20. Acidic pH- and metal ion (Zn++ or Mn++)-dependent proteolysis of 140 kDa atrial natriuretic factor receptor in bovine adrenal cortex plasma membranes: evidence for membrane-bound acidic metalloendopeptidase. Misono KS Biochem Biophys Res Commun; 1988 Apr; 152(2):658-67. PubMed ID: 2896502 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]